These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15710572)
1. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Petit B; Chaury MP; Le Clorennec C; Jaccard A; Gachard N; Moalic-Judge S; Labrousse F; Cogné M; Bordessoule D; Feuillard J Haematologica; 2005 Feb; 90(2):200-6. PubMed ID: 15710572 [TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
3. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012. Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704 [TBL] [Abstract][Full Text] [Related]
4. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. Zinzani PL; Dirnhofer S; Sabattini E; Alinari L; Piccaluga PP; Stefoni V; Tani M; Musuraca G; Marchi E; Falini B; Baccarani M; Pileri SA Haematologica; 2005 Mar; 90(3):341-7. PubMed ID: 15749666 [TBL] [Abstract][Full Text] [Related]
5. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome. Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20. Ramos-Vara JA; Miller MA; Valli VE Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900 [TBL] [Abstract][Full Text] [Related]
9. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030 [TBL] [Abstract][Full Text] [Related]
10. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour. Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516 [TBL] [Abstract][Full Text] [Related]
11. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608 [TBL] [Abstract][Full Text] [Related]
12. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Linderoth J; Jerkeman M; Cavallin-Ståhl E; Kvaløy S; Torlakovic E; Clin Cancer Res; 2003 Feb; 9(2):722-8. PubMed ID: 12576441 [TBL] [Abstract][Full Text] [Related]
14. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR; Nalesnik MA; Swerdlow SH Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518 [TBL] [Abstract][Full Text] [Related]
15. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura. Kambham N; Chang Y; Matsushima AY Clin Neuropathol; 1998; 17(6):311-7. PubMed ID: 9832258 [TBL] [Abstract][Full Text] [Related]
17. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Olszewski AJ; Castillo JJ Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605 [TBL] [Abstract][Full Text] [Related]
19. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318 [TBL] [Abstract][Full Text] [Related]
20. Marginal zone-related neoplasms of splenic and nodal origin. Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]